Page last updated: 2024-08-24

lamivudine and penciclovir

lamivudine has been researched along with penciclovir in 27 studies

Research

Studies (27)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	11 (40.74)	18.2507
2000's	11 (40.74)	29.6817
2010's	4 (14.81)	24.3611
2020's	1 (3.70)	2.80

Authors

Authors	Studies
Kumar, R; Tyrrell, DL	1
Kumar, R; Nath, M; Tyrrell, DL	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Bourke, DG; Coates, JA; Cox, S; Crosby, IT; Jeynes, TP; Jones, ED; Robertson, AD	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Korba, BE	1
Boyd, MR; Korba, BE	1
Colledge, D; Locarnini, S; Shaw, T	1
Fontana, RJ; Lok, AS	1
Jaeckel, E; Manns, MP	1
Chen, FC; Flavin, MT; Korba, BE; Lin, YM; Zembower, DE	1
Cheng, YC; Fu, L; Liu, SH	1
Carrilho, FJ; Kato, N; Lan, KH; Omata, M; Ono-Nita, SK; Shiratori, Y; Yoshida, H	1
Keating, MR	1
Civitico, G; Colledge, D; Locarnini, S; Shaw, T	1
De Clercq, E; Neyts, J; Ying, C	1
Cheng, YC; Fu, L	1
Addison, WR; Allen, MI; Condreay, LD; Tipples, GA; Tyrrell, L; Walters, KA	1
Razonable, RR	1

Reviews

3 review(s) available for lamivudine and penciclovir

Article	Year
Experience with lamivudine against hepatitis B virus. Intervirology, 1997, Volume: 40, Issue:5-6 Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Famciclovir; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunocompromised Host; Interferons; Lamivudine; Liver Transplantation; Mutation; Nucleosides; Reverse Transcriptase Inhibitors	1997
Antiviral agents for non-human immunodeficiency virus infections. Mayo Clinic proceedings, 1999, Volume: 74, Issue:12 Topics: 2-Aminopurine; Acetamides; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drugs, Investigational; Enzyme Inhibitors; Famciclovir; Foscarnet; Ganciclovir; Guanidines; Guanine; Humans; Interferons; Lamivudine; Neuraminidase; Organophosphonates; Organophosphorus Compounds; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Valacyclovir; Valine; Virus Diseases; Zanamivir	1999
Antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clinic proceedings, 2011, Volume: 86, Issue:10 Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir	2011

Other Studies

24 other study(ies) available for lamivudine and penciclovir

Article	Year
Novel 5-vinyl pyrimidine nucleosides with potent anti-hepatitis B virus activity. Bioorganic & medicinal chemistry letters, 2001, Nov-19, Volume: 11, Issue:22 Topics: Antiviral Agents; Hepatitis B virus; Humans; Indicators and Reagents; Molecular Conformation; Molecular Structure; Pyrimidine Nucleosides; Structure-Activity Relationship; Uracil	2001
Design and synthesis of novel 5-substituted acyclic pyrimidine nucleosides as potent and selective inhibitors of hepatitis B virus. Journal of medicinal chemistry, 2002, May-09, Volume: 45, Issue:10 Topics: Animals; Antineoplastic Agents; Antiviral Agents; Cell Division; Cells, Cultured; DNA; Drug Screening Assays, Antitumor; Ducks; Hepatitis B virus; Hepatitis B Virus, Duck; Hepatocytes; Humans; Pyrimidine Nucleosides; Structure-Activity Relationship; T-Lymphocytes	2002
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks. Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2 Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Antiviral agents 3. Discovery of a novel small molecule non-nucleoside inhibitor of hepatitis B virus (HBV). Bioorganic & medicinal chemistry letters, 2011, Mar-15, Volume: 21, Issue:6 Topics: Animals; Antiviral Agents; Drug Discovery; Hepatitis B virus	2011
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
In vitro evaluation of combination therapies against hepatitis B virus replication. Antiviral research, 1996, Volume: 29, Issue:1 Topics: Acyclovir; Antiviral Agents; Drug Synergism; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatoblastoma; Humans; Interferon-alpha; Lamivudine; Tumor Cells, Cultured; Virus Replication; Zalcitabine	1996
Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:5 Topics: Acyclovir; Antiviral Agents; Cell Line; Dideoxynucleosides; DNA-Directed DNA Polymerase; Guanine; Hepatitis B virus; Hepatoblastoma; Humans; Lamivudine; Microbial Sensitivity Tests; Virus Replication	1996
Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro. Hepatology (Baltimore, Md.), 1997, Volume: 26, Issue:1 Topics: Acyclovir; Animals; Antiviral Agents; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Ducks; Guanine; Hepatitis B Virus, Duck; Lamivudine; Liver; Virus Replication	1997
Combination therapy for chronic hepatitis B. Hepatology (Baltimore, Md.), 1997, Volume: 26, Issue:1 Topics: Acyclovir; Animals; Antiviral Agents; Cells, Cultured; Chronic Disease; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B Virus, Duck; Humans; Lamivudine; Liver; Virus Replication	1997
Drugs for non-HIV viral infections. The Medical letter on drugs and therapeutics, 1997, Aug-01, Volume: 39, Issue:1006 Topics: 2-Aminopurine; Abnormalities, Drug-Induced; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Contraindications; Cytosine; Drug Resistance, Microbial; Eye Infections, Viral; Famciclovir; Foscarnet; Ganciclovir; Guanine; Humans; Interferon-alpha; Kidney Diseases; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Ribavirin; Rimantadine; Trifluridine; Valacyclovir; Valine; Virus Diseases	1997
Robustaflavone, a potential non-nucleoside anti-hepatitis B agent. Antiviral research, 1998, Volume: 39, Issue:2 Topics: Acyclovir; Antiviral Agents; Biflavonoids; Cell Line; Drug Synergism; Flavonoids; Guanine; Hepatitis B virus; Lamivudine; Microbial Sensitivity Tests; Virus Replication	1998
Sensitivity of L-(-)2,3-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues. Biochemical pharmacology, 1999, Jun-15, Volume: 57, Issue:12 Topics: Acyclovir; Adenine; Antiviral Agents; Arabinofuranosyluracil; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Drug Resistance, Multiple; Guanine; Hepatitis B virus; Lamivudine; Microbial Sensitivity Tests; Mutation; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Zalcitabine	1999
Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors. The Journal of clinical investigation, 1999, Volume: 103, Issue:12 Topics: Acyclovir; Adenine; Carcinoma, Hepatocellular; Drug Resistance, Microbial; Guanine; Hepatitis B virus; Humans; Lamivudine; Mutagenesis, Site-Directed; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Transfection; Tumor Cells, Cultured	1999
In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:3 Topics: Acyclovir; Adenine; Animals; Antiviral Agents; Cells, Cultured; Drug Interactions; Drug Therapy, Combination; Ducks; Guanine; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Humans; Lamivudine; Liver; Organophosphonates; Virus Replication	2000
Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell culture. Journal of viral hepatitis, 2000, Volume: 7, Issue:1 Topics: Acyclovir; Adenine; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Guanine; Hepatitis B virus; Lamivudine; Organophosphonates; Organophosphorus Compounds; Tenofovir; Tumor Cells, Cultured	2000
Drugs for non-HIV viral infections. The Medical letter on drugs and therapeutics, 1999, Dec-03, Volume: 41, Issue:1067 Topics: 2-Aminopurine; Acetamides; Acyclovir; Aged; Amantadine; Animals; Anti-HIV Agents; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enzyme Inhibitors; Famciclovir; Ganciclovir; Guanidines; Guanine; Herpes Simplex; Herpes Zoster; History, 18th Century; HIV Infections; Humans; Injections, Intravenous; Interferon-alpha; Lamivudine; Neuraminidase; Oseltamivir; Pyrans; Rats; Ribavirin; Sialic Acids; Teratogens; Valacyclovir; Valine; Zanamivir	1999
Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:12 Topics: Acyclovir; Antigens, Viral; Antiviral Agents; Carcinoma, Hepatocellular; Drug Resistance, Microbial; Guanine; Hepatitis B virus; Humans; Lamivudine; Liver Neoplasms; Microbial Sensitivity Tests; Time Factors; Transfection; Tumor Cells, Cultured; Virus Replication	2000
Drugs for non-HIV viral infections. The Medical letter on drugs and therapeutics, 2002, Feb-04, Volume: 44, Issue:1123 Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Administration, Topical; Amantadine; Animals; Antiviral Agents; Cidofovir; Cytosine; Famciclovir; Foscarnet; Guanine; Herpesviridae Infections; Humans; Influenza, Human; Injections, Intravenous; Lamivudine; Organophosphonates; Organophosphorus Compounds; Rats; Ribavirin; Rimantadine; Thionucleotides; Trifluridine; Valacyclovir; Valine	2002
Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:6 Topics: Acyclovir; Antiviral Agents; Base Sequence; Deoxyguanosine; Dideoxynucleosides; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed; Transfection; Tumor Cells, Cultured; Virus Replication	2003